| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.05 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.05 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.06 |